STH BIOTECH Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $1.07M

  • Investors
  • 7

STH BIOTECH General Information

Description

Developer of a biotechnology platform designed to extract cannabis-based therapeutic compounds for pharmaceutical innovation. The company offers a plant-biotech process for producing cannabinoids and other plant bioactives at high yield and low cost, enabling pharmaceutical researchers and cosmetic manufacturers to develop new drugs and innovative ingredients with improved efficiency.

Contact Information

Website
www.sth-biotech.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Genopole
  • 4 Rue Pierre Fontaine
  • 91000 Évry-Courcouronnes
  • France
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Specialty Chemicals
Biotechnology
Vertical(s)
Cannabis, Beauty, HealthTech, Life Sciences
Corporate Office
  • Genopole
  • 4 Rue Pierre Fontaine
  • 91000 Évry-Courcouronnes
  • France

STH BIOTECH Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

STH BIOTECH Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC 01-May-2024 $1.07M Completed Product Development
5. Accelerator/Incubator 06-Jul-2023 Completed Product Development
4. Accelerator/Incubator 01-Jan-2023 Completed Startup
3. Accelerator/Incubator 20-Jun-2023 Completed Product Development
2. Accelerator/Incubator 01-Jan-2022 $250K $250K Completed Product Development
1. Accelerator/Incubator 25-Oct-2021 Completed Startup
To view STH BIOTECH’s complete valuation and funding history, request access »

STH BIOTECH Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

STH BIOTECH Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bpifrance Sovereign Wealth Fund Minority
Calyseed Venture Capital Minority
Sharpstone Capital Venture Capital Minority
Wilco(Paris) Accelerator/Incubator
Hello Tomorrow Accelerator/Incubator
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

STH BIOTECH FAQs

  • When was STH BIOTECH founded?

    STH BIOTECH was founded in 2021.

  • Where is STH BIOTECH headquartered?

    STH BIOTECH is headquartered in Évry-Courcouronnes, France.

  • What is the size of STH BIOTECH?

    STH BIOTECH has 8 total employees.

  • What industry is STH BIOTECH in?

    STH BIOTECH’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is STH BIOTECH a private or public company?

    STH BIOTECH is a Private company.

  • What is STH BIOTECH’s current revenue?

    The current revenue for STH BIOTECH is .

  • How much funding has STH BIOTECH raised over time?

    STH BIOTECH has raised $1.97M.

  • Who are STH BIOTECH’s investors?

    Bpifrance, Calyseed, Sharpstone Capital, Wilco(Paris), and Hello Tomorrow are 5 of 7 investors who have invested in STH BIOTECH.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process